Denning KL - Search Results

1

Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Series.

Ranjan T, Howard CM, Yu A, Xu L, Aziz K, Jho D, Leonardo J, Hameed MA, Karlovits SM, Wegner RE, Fuhrer R, Lirette ST, Denning KL, Valluri J, Claudio PP. Ranjan T, et al. Among authors: denning kl. Transl Oncol. 2020 Apr;13(4):100755. doi: 10.1016/j.tranon.2020.100755. Epub 2020 Mar 17. Transl Oncol. 2020. PMID: 32197147 Free PMC article.

2

Chemo-predictive assay for targeting cancer stem-like cells in patients affected by brain tumors.

Mathis SE, Alberico A, Nande R, Neto W, Lawrence L, McCallister DR, Denvir J, Kimmey GA, Mogul M, Oakley G 3rd, Denning KL, Dougherty T, Valluri JV, Claudio PP. Mathis SE, et al. Among authors: denning kl. PLoS One. 2014 Aug 21;9(8):e105710. doi: 10.1371/journal.pone.0105710. eCollection 2014. PLoS One. 2014. PMID: 25144312 Free PMC article.

3

FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC.

Morra F, Luise C, Merolla F, Poser I, Visconti R, Ilardi G, Paladino S, Inuzuka H, Guggino G, Monaco R, Colecchia D, Monaco G, Cerrato A, Chiariello M, Denning K, Claudio PP, Staibano S, Celetti A. Morra F, et al. Oncotarget. 2015 May 20;6(14):12697-709. doi: 10.18632/oncotarget.3708. Oncotarget. 2015. PMID: 25885523 Free PMC article.

4

Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients.

Howard CM, Valluri J, Alberico A, Julien T, Mazagri R, Marsh R, Alastair H, Cortese A, Griswold M, Wang W, Denning K, Brown L, Claudio PP. Howard CM, et al. Transl Oncol. 2017 Apr;10(2):241-254. doi: 10.1016/j.tranon.2017.01.008. Epub 2017 Feb 12. Transl Oncol. 2017. PMID: 28199863 Free PMC article.

5

Minimally Manipulative Method for the Expansion of Human Bone Marrow Mesenchymal Stem Cells to Treat Osseous Defects.

Lawrence LM, Cottrill A, Valluri A, Marenzi G, Denning KL, Valluri J, Claudio PP, Day JB. Lawrence LM, et al. Among authors: denning kl. Int J Mol Sci. 2019 Jan 31;20(3):612. doi: 10.3390/ijms20030612. Int J Mol Sci. 2019. PMID: 30708975 Free PMC article.

6

Expression of poly-ADP-ribose polymerase (PARP) in endometrial adenocarcinoma: Prognostic potential.

Lawrence LM, Russell R, Denning CE, Zgheib NB, Salisbury T, Lirette ST, Valluri J, Claudio PP, Denning KL. Lawrence LM, et al. Among authors: denning ce, denning kl. Pathol Res Pract. 2020 Jun;216(6):152965. doi: 10.1016/j.prp.2020.152965. Epub 2020 Apr 21. Pathol Res Pract. 2020. PMID: 32360251 Free article.

7

Clinical relevance of cancer stem cell chemotherapeutic assay for recurrent ovarian cancer.

Howard CM, Zgheib NB, Bush S 2nd, DeEulis T, Cortese A, Mollo A, Lirette ST, Denning K, Valluri J, Claudio PP. Howard CM, et al. Transl Oncol. 2020 Dec;13(12):100860. doi: 10.1016/j.tranon.2020.100860. Epub 2020 Aug 28. Transl Oncol. 2020. PMID: 32862103 Free PMC article.

8

Osteoregenerative Potential of 3D-Printed Poly ε-Caprolactone Tissue Scaffolds In Vitro Using Minimally Manipulative Expansion of Primary Human Bone Marrow Stem Cells.

Lawrence LM, Salary RR, Miller V, Valluri A, Denning KL, Case-Perry S, Abdelgaber K, Smith S, Claudio PP, Day JB. Lawrence LM, et al. Among authors: denning kl. Int J Mol Sci. 2023 Mar 3;24(5):4940. doi: 10.3390/ijms24054940. Int J Mol Sci. 2023. PMID: 36902373 Free PMC article.

9

Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.

Ranjan T, Sengupta S, Glantz MJ, Green RM, Yu A, Aregawi D, Chaudhary R, Chen R, Zuccarello M, Lu-Emerson C, Moulding HD, Belman N, Glass J, Mammoser A, Anderson M, Valluri J, Marko N, Schroeder J, Jubelirer S, Chow F, Claudio PP, Alberico AM, Lirette ST, Denning KL, Howard CM. Ranjan T, et al. Among authors: denning kl. Cell Rep Med. 2023 May 16;4(5):101025. doi: 10.1016/j.xcrm.2023.101025. Epub 2023 May 2. Cell Rep Med. 2023. PMID: 37137304 Free PMC article. Clinical Trial.

10

Treatment of unmethylated MGMT-promoter recurrent glioblastoma with cancer stem cell assay-guided chemotherapy and the impact on patients' healthcare costs.

Ranjan T, Yu A, Elhamdani S, Howard CM, Lirette ST, Denning KL, Valluri J, Claudio PP. Ranjan T, et al. Among authors: denning kl. Neurooncol Adv. 2023 May 12;5(1):vdad055. doi: 10.1093/noajnl/vdad055. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37287692 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters